Accelerated fractionation (AF) compared to conventional fractionation (CF) improves loco-regional control in the radiotherapy of advanced head and neck cancers: results of the EORTC 22851 randomized trial

This publication has 23 references indexed in Scilit:

• 110Conventional radiotherapy as the primary treatment of squamous cell carcinoma (SCC) of the head and neck. A randomized multicenter study of 5 versus 6 fractions per week — Preliminary report from the Dahanca 6 and 7 trial
  Radiotherapy and Oncology, 1996
• 108Overall time factor in postoperative radiation: Results of a prospective randomized trial
  Radiotherapy and Oncology, 1996
• The EORTC randomized trial on three fractions per day and misonidazole in advanced head and neck cancer: prognostic factors
  Radiotherapy and Oncology, 1995
• The EORTC randomized trial on three fractions per day and misonidazole (trial no. 22811) in advanced head and neck cancer: long-term results and side effects
  Radiotherapy and Oncology, 1995
• Loss of local control with prolongation in radiotherapy
  International Journal of Radiation Oncology*Biology*Physics, 1992
• Local control of oropharyngeal carcinoma after two accelerated hyperfractionation radiation therapy schemes
  International Journal of Radiation Oncology*Biology*Physics, 1988
• Late results of multiple fractions per day (MFD) with misonidazole in advanced cancer of the head and neck. A pilot study of the EORTC radiotherapy group
  Radiotherapy and Oncology, 1985
• Tables of the number of patients required in clinical trials using the logrank test
  Statistics in Medicine, 1982
• A re-evaluation of split-course technique for squamous cell carcinoma of the head and neck
  International Journal of Radiation Oncology*Biology*Physics, 1980
• Nonparametric Estimation from Incomplete Observations
  Journal of the American Statistical Association, 1958